The formation constants and structures of copper(II)-glycinehydroxamic acid complexes

Formation constants for the complexes formed between copper(II) and glycinehydroxamic acid (H₂NCH₂CONHOH) have been measured potentiometrically at 25.0 °C and I = 0.10 M (NaClO₄). The existence of a dimeric copper(II) species has been shown from the line broadening of the epr spectrum of a solution at room temperature. The structures of the complexes are discussed and conclusions are drawn based on absorption and epr spectra.     

Copper(II) complexes of methimazole,an anti Grave’s disease drug. Synthesis,characterization and its potential biological behavior as alkaline phosphatase inhibitor

Methimazole (MeimzH) is an anti-thyroid drug and the first choice for patients with Grave’s disease. Two new copper(II) complexes of this drug: [Cu(MeimzH)₂(NO₃)₂].0.5H₂O and [Cu(MeimzH)₂(H₂O)₂](NO₃)₂·H₂O were synthesized and characterized by elemental analysis, dissolution behavior, thermogravimetric analysis and UV-vis, diffuse reflectance, FTIR and EPR spectroscopies. As it is known that copper(II) cation can act as an inhibitor of alkaline phosphatase (ALP), the inhibitory effect of methimazole and its copper(II) complexes on ALP activity has also been investigated.     

Metal complexes with schiff bases obtained from salicylaldehyde derivatives and 2-aminoethylpyridine

Cobalt(II), cobalt(III), nickel(II), copper(II) and palladium(II) complexes with N-2-(2-pyridyl)ethylring-substituted salicylideneiminates (abbreviated as X-Sal-2-Epy) were synthesized. In addition to Co^III (H-Sal-2-Epy)₃, the complexes of the formula M^II(X-Sal-2-Epy)₂·nH₂O were obtained in crystals. The cobalt(III) complex is diamagnetic and has an electronic absorption spectrum typical of the six-coordinate, octahedral cobalt(III) complex. The cobalt(II) complexes in the solid state show electronic spectra typical of the six-coordinate cobalt(II) complexes. Electronic spectra also indicate that the nickel(II) complexes in the solid state and in non-donor solvents are six-coordinate, octahedral. In the cobalt(II) and nickel(II) complexes, the ligand X-Sal-2-Epy functions as terdentates, while in the cobalt(III) complex it acts as a bidentate ligand. The results are compared with those reported previously for related ligands.     

1,10-Phenanthroline-dithiolate mixed ligand transition metal complexes. Synthesis, characterization and EPR spectroscopy

A series of new N₂S₂ mixed ligand transition metal complexes, where N₂ is phenanthroline and S₂ is 1,2-dithiooxalate (dto) or 1,2-dithiosquarate (dtsq), has been synthesized and characterized. IR spectra reveal that the 1,2-dithiolate ligands are coordinated via the sulfur atoms forming a N₂S₂ coordination sphere. The copper(II) complex [Cu(phen)(dto)] was studied by EPR spectroscopy as a diamagnetically diluted powder. The diamagnetic dilution resulted from doping of the copper complex into the isostructural host lattice of the nickel complex [Ni(phen)(dto)]. The electronic situation in the frontier orbitals of the copper complex calculated from the experimental data is compared to the results of EHT and DFT calculations. Furthermore, one side product, chlorobis(1,10-phenanthroline)copper(I) ethanol solvate hydrate [(phen)₂CuCl]·C₂H₅OH·H₂O, was formed by a reduction process and characterized by X-ray diffraction. In the crystal packing one-dimensional columns of dimers are formed, stabilized by significant π-π interactions.     

Metal chelates of heterocyclic nitrogen-containing ketones. XX. Temperature dependence of magnetic susceptibility and electron spin resonance spectra of halogeno-copper(II) complexes of phenyl-2-picolyl ketone hydrazone and phenyl hydrazone

The interaction of hydrated copper(II) chloride or bromide with phenyl-2-picolyl ketone hydrazone and phenyl-2-picolyl ketone phenyl hydrazone, PPKhy and PPKPhy, respectively, have been studied employing elemental analyses, spectral studies (IR and electronic spectra) and the variable temperature magnetic susceptibility together with the electron spin resonance spectra. The complexes of the formulae [CuLX₂]₂, L = PPKhy or PPKPhy and X = Cl or Br, are found to be dimeric through a halide bridge while those of the stoichiometry [CuL₂]X₂ are monomeric in nature. The magnetic data showed that the dimeric complexes possess antiferromagnetic interaction. The mechanism of the magnetic interaction is discussed based on the variable temperature magnetic data and ESR spectra.     

Bis(isocyclam)dicopper(II) complexes with a linear methylene chain bridge

New binucleating ligands, bis(isocyclam) with a linear methylene chain bridge, n-bicy (n = 2, 3, 4) and their copper(II) complexes, Cu₂(n-bicy)(ClO₄)₄· xH₂O and Cu₂(n-bicy)(NCS)₄·yH₂O have been synthesized. The magnetic moments of these complexes were normal, but the presence of magnetic coupling between copper(II) ions were clearly demonstrated by the hyperfine structure in the ESR spectra.     

Square-planar copper(II) complexes with tetradentate amido-carboxylate ligands. Crystal structure of Na2[Cu(obap)]2 · 2H2O. Strain analysis and spectral assignments of complexes

Novel N-N-N-O-type of tetradentate ligands H₃obap (H₃obap = oxamido-N-aminopropyl-N′-benzoic acid) and H₃maeb (H₃maeb = malamido-N-aminoethyl-N′-benzoic acid) and the corresponding square-planar copper(II) complexes have been prepared and characterized. The obap³⁻ and maeb³⁻ ligands coordinate to the copper(II) ion via four ligating atoms (three deprotonated atoms: one carboxylate oxygen and two deprotonated amide nitrogens; one amine nitrogen) with in-plane square chelation. A four coordinate, square-planar geometry has been established crystallographically for the binuclear Na₂[Cu(obap)]₂ · 2H₂O complex. Structural data correlating the square-planar geometry of the [Cu(obap)]⁻ unit and an extensive strain analysis are discussed in relation to the information obtained for similar complexes. The infrared and electronic absorption spectra of the complexes are discussed in comparison to the related complexes of known geometries. Antibacterial activity of ligands and copper(II) complexes towards common Gram-negative and Gram-positive bacteria are reported as well.     

Synthesis, crystal structure, cytotoxic activities and DNA-binding properties of new binuclear copper(II) complexes bridged by N,N′-bis(N-hydroxyethylaminoethyl)oxamide

Two new μ-oxamido-bridged binuclear copper(II) complexes with formulae of [Cu₂(heae)(pic)₂] (1) and [Cu₂(heae)(Me₂phen)₂](ClO₄)₂ · H₂O (2), where heae and pic stand for the anion of N,N′-bis(N-hydroxyethylaminoethyl)oxamide and 2,4,6-trinitrophenol, respectively, and Me₂phen represents 2,9-dimethyl-1,10-phenanthroline; have been synthesized and characterized by elemental analyses, molar conductivity measurements, IR and electronic spectra studies. The crystal structures of the two binuclear copper(II) complexes have been determined by X-ray single-crystal diffraction. In both the two binuclear complexes the central two copper(II) atoms are bridged by trans-heae. In complex 1 the coordination environment around each copper(II) atom can be described as a distorted octahedral geometry, while in complex 2 each copper(II) atom displays a square-pyramid stereochemistry. Hydrogen bonding and π-π stacking interactions link the binuclear copper(II) complex 1 or 2 into a 3D infinite network. The cytotoxicities of the two binuclear copper(II) complexes were tested by Sulforhodamine B (SRB) assays against human hepatocellular carcinoma cell SMMC-7721 and human lung adenocarcinoma cell A549. Both of the two binuclear copper(II) complexes exhibit potent cytotoxic effects against SMMC-7721 and A549 cell lines. The interactions of the two binuclear complexes with herring sperm DNA (HS-DNA) are investigated by using absorption and emission spectra and electrochemical techniques and viscometry. The results suggest that both the two binuclear copper(II) complexes interact with HS-DNA in the mode of intercalation with the intrinsic binding constants of 1.73 × 10⁵ M⁻¹ (1) and 1.92 × 10⁶ M⁻¹ (2). The influence of structural variation of the terminal ligands in the binuclear complexes on DNA-binding properties is preliminarily discussed.     

Copper(II) complexes as superoxide dismutase mimics: Synthesis, characterization, crystal structure and bioactivity of copper(II) complexes

Two new copper(II) complexes of the type [Cu(L)X₂), where L = (E)-N-phenyl-2-[phenyl (pyridine-2-yl)methylene]hydrazinecarboxamide X = Cl/Br have been synthesized and characterized by elemental analyses, FAB (fast atomic bombardment) magnetic measurements, electronic absorption, conductivity measurements cyclic voltammetry (CV) and Electron paramagnetic resonance (epr) spectroscopy. The structures of these complexes determined by single crystal X-ray crystallography show a distorted square based pyramidal (DSBP) geometry around copper(II) metal center. The distorted CuN₂OX (X = Cl/Br) basal plane in them is comprised of two nitrogen and one oxygen atoms of the meridionally coordinated ligand and a chloride or bromide ion and axial position is occupied by other halide ion. The epr spectra of these complexes in frozen solutions of DMSO showed a signal at g ca. 2. The trend in g-value (g_|| > g_⊥ > 2.00) suggest that the unpaired electron on copper(II) has d_x²-y² character. Biological activities in terms of superoxide dismutase (SOD) and antimicrobial properties of copper(II) complexes have also been measured. The superoxide dismutase activity reveals that these two complexes catalyze the fast disproportionation of superoxide in DMSO solution.     

Hypoglycemic effect of copper(II) acetate imidazole complexes

The effect of copper(II) complexes on glucose metabolism was studied in normal and streptozotocin-induced diabetic rats. The copper(II) complexes used were bis(acetato)tetrakis(imidazole) copper (II), [Cu(OAc)₂(Im)₄], bis(acetato)bis(2-methylimidazole) copper(II), [Cu(OAc)₂(1,2dmIm)₂], and bis)acetato)bis(μ-acetato)tetrakis(N-methylimidazole) copper(II) hexaaquo, [Cu₂(OAc)₄-(NmIm)₄]·6H₂O. Intramuscular administration of various doses of Cu(OAc)₂(Im)₄ ranging from 10 to 100 mg/kg body mass to overnight fasted rats decreased blood glucose levels in a dose-dependent manner. Maximum hypoglycemic effect was observed 3 h after administration and lasted for at least 6 h. Treatment with 100 mg/kg body mass of Cu(OAc)₂(Im)4 caused hypoglycemic shock, which was irreversible and even lethal. Blood insulin levels were reduced sharply during this hypoglycemic shock. Similar changes in blood glucose level were achieved using Cu(OAc)₂)2mIm)₂. The same pattern of hypoglycemia, although less pronouned, was observed for Cu₂(OAc)₄(NmIm)₄·6H₂O and Cu (OAc)₂(1,2dmIm)₂. Binary copper(II) acetate complex, the ligand imidazole, and the inorganic form of copper, such as copper(II) chloride, had no significant effect on blood glucose level. These results indicate that the hypoglycemic activity of these complexes varies with the imidazole ligand and structure of the complex. Intramuscular administration of Cu(OAc)₂(Im)₄ to diabetic rats caused a reduction in blood glucose levels and improved their tolerance for glucose.     

Superoxide dismutase activity of macrocyclic polyamine complexes

Copper(II) and nickel(II) complexes of macrocyclic polyamine derivatives possessing partial oligopeptide-like structures are found to suppress the xanthine-xanthine oxidase-mediated reduction of nitroblue tetrazolium and also to suppress formazan formation by potassium superoxide. The activity in the superoxide dismutase assay is dependent on ring size, type and number of donor atoms, metal ion, and substituents on the macrocycles. Some of those are more active than the known O₂^? scavengers such as copper(II)-salicylate and copper(II)-amino acid (or peptide) complexes. Nickel (II)-naphthylmethyl-dioxo-[16]ane N₅, 13, 1 : 1 complex (NiH_?2L) is the most active among the 30 chelates examined.     

Deuteron NMR spectroscopy of copper(II) complexes in solution. 1. (5,7,7,12,14,14,-hexamethyl-1,4,8,1 1-tetraazacyclotetradeca-4,11-diene)-copper(II) and its derivatives in nonaqueous solvent

¹H and ²H NMR spectra of the title copper(II) complexes and its derivatives have been measured. In contrast with their ¹H NMR spectra, ²H NMR spectra gave well resolved sharp signals, and demonstrated that two diastereomers attributable to two asymmetric ligand nitrogens are readily resolved. The remarkable linewidth-narrowing was found in the peripheral methyl groups, which make ²H NMR spectra very useful even for copper(II) complexes with a long electron spin relaxation time. By using ²H NMR spectra, meso-racemate equilibrium was pursued and examined in aqueous and acetonitrile solutions.     

Interaction of copper (II) complexes by bovine serum albumin: spectroscopic and calorimetric insights

Serum albumins being the most abundant proteins in the blood and cerebrospinal fluid are significant carriers of essential transition metal ions in the human body. Studies of copper (II) complexes have gained attention because of their potential applications in synthetic, biological, and industrial processes. Study of binding interactions of such bioinorganic complexes with serum albumins improves our understanding of biomolecular recognition process essential for rational drug design. In the present investigation, we have applied quantitative approach to explore interactions of novel synthesized copper (II) complexes viz. [Cu(L¹)(L²)ClO₄] (complex I), [Cu(L²)(L³)]ClO₄] (complex II) and [Cu(L⁴)₂(H₂O)₂] (complex III) with bovine serum albumin (BSA) to evaluate their binding characteristics, site and mode of interaction. The fluorescence quenching of BSA initiated by complexation has been observed to be static in nature. The binding interactions are endothermic driven by entropic factors as confirmed by high sensitivity isothermal titration calorimetry. Changes in secondary and tertiary structure of protein have been studied by circular dichroism and significant reduction in α-helical content of BSA was observed upon binding. Site marking experiments with warfarin and ibuprofen indicated that copper complexes bind at site II of the protein.     

Model complexes of the active site of galactose oxidase. Effects of the metal ion binding sites

Model compounds of the active site of galactose oxidase have been developed by using new cofactor model ligands, L1H (2-methylthio-4-tert-butyl-6-[{bis(pyridin-2-ylmethyl)amino}methyl]phenol) and L2H (2-methylthio-4-tert-butyl-6-[{bis(6-methylpyridin-2-ylmethyl)amino}methyl]phenol). Treatment of the ligands with copper(II) and zinc(II) perchlorate in the presence of triethylamine followed by anion exchange reaction with NaPF₆ or NaBPh₄ provided the corresponding copper(II) and zinc(II) complexes, the crystal structures of which have been determined by X-ray crystallographic analysis. All the copper(II) and zinc(II) complexes have been isolated as a dimeric form in which the phenolate oxygen of each ligand acts as the bridging ligand to form a rhombic M₂(OAr)₂ core (M=Cu or Zn). The dimeric complexes can be converted into the corresponding monomer complexes by the treatment with exogenous ligand such as acetate ion. The redox potential and the spectroscopic features of the monomer complexes have also been examined. Furthermore, the copper(II)- and zinc(II)-complexes of the phenoxyl radical species of the ligands have been generated in situ by the oxidation of the phenolate complexes with (NH₄)₂[Ce^IV(NO₃)₆] (CAN) in CH₃CN, and their spectroscopic features have been explored. The structures and physicochemical properties of the phenolate and phenoxyl radical complexes of L1 and L2 have been compared to those of the previously reported copper(II) and zinc(II) complexes of L3 (2-methylthio-4-tert-butyl-6-[{bis(2-pyridin-2-ylethyl)amino}methyl]phenol) in order to get insights into the interaction between the metal ions and the organic cofactor moiety.     

Synthesis, spectroscopic characterization and radiosensitizing properties of acetato-bridged copper(II) complexes with 5-nitroimidazole drugs

Three novel acetato-bridged dinuclear copper(II) complexes with 5-nitroimidazoles (CuAcNtrim) and the known copper-acetato-metronidazole have been prepared by an environment-friendly route and spectroscopically characterized. The CuAcNtrim compounds of formula [Cu₂(μ-O₂CCH₃)₄Ntrim₂], where Ntrim = metronidazole (1), secnidazole (2), tinidazole (3) or nimorazole (4), exhibit dimeric copper-acetato paddle-wheel structures with Ntrim axial ligands coordinated to copper(II) ions through the N₃ atoms of the imidazole rings. EPR data indicate antiferromagnetic behavior for this novel series of copper complexes. The constant coupling has been found to decrease along with the increasing of basicity of the Ntrim axial ligand. The CuAcNtrim complexes and the correspondent Ntrim parent drugs have shown radiosensitizer properties for Hep2 (human larynx cancer) cell line in vitro. The best enhancement of radiosensitizer activity upon coordination of the Ntrim drug to copper(II) has been found for the nimorazole compound which has the strongest Cu-Ntrim bond and exhibits the highest lipophilicity within the series of CuAcNtrim complexes.     

Copper(II) complexes with an avian prion N-terminal region and their potential SOD-like activity

Potentiometric and spectroscopic (UV-Vis, CD and EPR) studies were carried out on copper(II) complexes with chicken prion protein N-terminal fragments, Ac-(PHNPGY)₄-NH₂, and the mutated residue, Ac-(PHNPGF)₄-NH₂, to assess the role of tyrosine in the copper coordination. Both thermodynamic and spectroscopic results indicate that chicken prion fragments are not able to bind more than two copper ions and only with the involvement of side chain tyrosine groups. The prevailing complex shows one copper ion bound to four imidazole nitrogen atoms in the 1:1 metal to ligand ratio systems. The superoxide dismutase (SOD)-like activity of copper(II) complexes with the avian peptides and mammal analogue, Ac-(PHGGGWGQ)₄-NH₂, was also investigated by means of Pulse radiolysis. The copper(II) complexes with avian peptides do not display SOD-like activity, while very low activity has been detected for the copper(II) complexes with mammalian tetraoctarepeat.     

Copper complexes with new oxaaza-pendant-armed macrocyclic ligands: X-ray crystal structure of a macrocyclic copper(II) complex

The synthesis of new oxaaza macrocyclic ligands (2-4) derived from O¹,O⁷-bis(2-formylphenyl)-1,4,7-trioxaheptane and functionalized tris(2-aminoethyl)amine are described. Mononuclear copper(II) complexes were isolated in the reaction of the corresponding macrocyclic ligand and copper(II) perchlorate. The structure of the [Cu(2)](ClO₄)₂ complex was determined by X-ray diffraction analysis. The copper(II) ion is five-coordinated by all N₅ donor atoms, efficiently encapsulated by the amine terminal pendant-arm, with a trigonal-bipyramidal geometry. The complexes are further characterized by UV-Vis, IR and EPR studies. The electronic reflectance spectra evidence that the coordination geometry for the Cu(II) complexes is trigonal-bipyramidal with the ligands 1 and 2 or distorted square-pyramidal with the ligands 3 and 4. The electronic spectra in MeCN solutions are different from those in the solid state, which suggest that some structural modification may occur in solution. The EPR spectrum of powder samples of the copper complex with 2 presents axial symmetry with hyperfine split at g_// with the copper nuclei (I = 3/2), which is characteristic of weakly exchange coupled extended systems. The EPR parameters (g_// = 2.230, A_// = 156 × 10⁻⁴ cm⁻¹ and g_⊥ = 2.085) indicate a d_x²-y² ground state. The EPR spectra of the complexes with ligands 3 and 4 show EPR spectra with a poorly resolved hyperfine structure at g_//. In contrast, the complex with ligand 2 shows no hyperfine split and a line shape which was simulated assuming rhombic g-tensor (g₁ = 2.030, g₂ = 2.115 and g₃ = 2.190).     

Copper complexes of some tetradentate pyrazolyl amines

Four tetradentate nitrogen donor ligands have been prepared by condensation of N-hydroxymethylpyrazoles with ethylenediamines. These ligands are varied by methylation of the pyrazole rings (edbd) or the aminonitrogens (debp), or both (debd). Copper(II) complexes of the type CuL(ClO₄)₂ have been isolated with L = debp, edbp, edbd. For L = debd, the adducts salts Cu(debd)(dMp)X₂, with X = ClO₄⁻, BF₄⁻ and dMp = 3,5-dimethylpyrazole, were obtained. The compounds were characterized by their absorption (d-d) and EPR spectra. All four undergo quasi-reversible electrochemical reduction in methanol, the redox potentials being correlated with the degree of ligand methylation. The copper(I) forms are relatively unstable, and also bind carbon monoxide with different affinities.     

Potentiometric and spectroscopic studies on the solution molecular structures of copper(II)-[S]-2-[N-(2′-hydroxybenzyl)aminomethyl]pyrrolidine complexes, potential non-steroidal anti-inflammatory agents (NSAIDs)

The purpose of this study was to investigate the complexes formed by copper(II) with potential non-steroidal anti-inflammatory agents (NSAIDs) under physiological conditions. A former study suggested that 2-benzylaminomethylpyrrolidine ligands could be good candidates as potential OIL (OH-inactivating ligand) when complexed to copper(II). In order to assess the chemical behavior as OIL, [S]-2-[N-(2′-hydroxybenzyl)aminomethyl]pyrrolidine (OHbamp) was synthesized and bound to copper(II). Physico-chemical properties were determined at 37 °C in 0.15 M NaCl using glass electrode potentiometry, UV-Vis and circular dichroism spectroscopies, before and after copper(II) complexation. [Cu(OHbamp)(H₂O)₃]⁺ was the main complex found at both physiological and inflammatory pH values, showing appreciable stability at pathological pH compared to copper(II) complexes of histidine, the predominant low-molar-mass ligand of copper(II) in blood plasma. However, neutral species such as [Cu(OHbamp)₂(H₂O)₂] and [Cu(OHbamp)(OH)(H₂O)₃] are predominant only above pH 8, preventing a significant amount of drug from diffusing through membranes at inflammatory pH. In conclusion, copper(II)-OHbamp system does not meet all the requirements to be an OIL. Nevertheless, these results allow us to better identify the chemical features needed for a good OIL candidate.     

Investigations into some aryl substituted bis(thiosemicarbazones) and their copper complexes

The synthesis of three bis(thiosemicarbazone) compounds formed by the reaction of benzil with either thiosemicarbazide, 4-methyl-3-thiosemicarbazide or 4-phenyl-3-thiosemicarbazide are reported. The compounds were characterised by NMR spectroscopy, mass spectrometry and in the case of benzil bis(4-methyl-3-thiosemicarbazone) and benzil bis(4-phenyl-3-thiosemicarbazone) by X-ray crystallography. Attempts to purify benzil bis(thiosemicarbazone) and benzil bis (4-methyl-3-thiosemicarbazone) by recrystallisation resulted in the isolation of cyclised products that were characterised by X-ray crystallography. The 3 bis(thiosemicarbazone) compounds were used to synthesise both Cu(II) and Cu(I) complexes. The copper(II) complexes were formed by the reaction of the proligands with copper(II) acetate which gave neutral copper(II) complexes in which the thiosemicarbazone is doubly deprotonated, acting as a dianionic ligand. The copper(II)-benzil bis(4-phenyl-3-thiosemicarbazonato) complex was characterised by X-ray crystallography to show the copper in an essentially square planar N₂S₂ environment. The copper(I) complexes were synthesised by reacting the bis (thiosemicarbazone) ligands with [Cu(CH₃CN)₄]PF₆ to give cationic complexes. The copper(I)-benzil-bis(thiosemicarbazone) complex was characterised by X-ray crystallography which revealed that the complex was a dimeric dication. Each of the benzil bis(thiosemicarbazone) ligands act as a bidentate N,S donor to each copper(I) atom, forming an overall helical structure in which each copper atom is in a strongly distorted tetrahedral N₂S₂ environment. Electrochemical measurements show that the copper(II)-benzil bis(thiosemicarbazonato) complex undergoes a reversible reduction at biologically accessible potentials.